HeartSine Technologies, Ltd. Issues Global Correction Of Samaritan® 300/300P PAD

by FDA on October 25, 2012

in FDA Recalls,Food Recalls

On September 13, 2012, HeartSine Technologies, Ltd. initiated a voluntary global correction of certain Samaritan® 300/300P PAD public access defibrillators to address two separate issues that may affect the ability to deliver therapy to a patient in a sudden cardiac arrest (SCA) event, if needed. Certain Samaritan® 300/300P PAD devices manufactured before December 2010 have been found to intermittently turn on and off, which may eventually deplete the battery.

This is a summary of a recall issued by the Food and Drug Administration (FDA). The link below will take you to the original recall press release containing complete information, including instructions about what to do if you are affected by this recall.

View Full Details Of Original FDA Recall Notice Here.

Leave a Comment

Previous post:

Next post: